Over the last 7 days, the United States market has remained flat, yet it is up 25% over the past year with earnings expected to grow by 17% annually in the coming years. In this context of robust growth and stability, identifying high-growth tech stocks involves focusing on companies that demonstrate strong innovation capabilities and adaptability to evolving market demands.

Top 10 High Growth Tech Companies In The United States

Name	Revenue Growth	Earnings Growth	Growth Rating
AppLovin	20.91%	21.48%	★★★★★★
Reddit	21.88%	25.35%	★★★★★★
Krystal Biotech	29.09%	36.48%	★★★★★★
Palantir Technologies	29.33%	30.33%	★★★★★★
Fabrinet	21.38%	23.34%	★★★★★★
Marker Therapeutics	61.33%	65.71%	★★★★★★
Flex	20.01%	42.24%	★★★★★★
KVH Industries	28.67%	146.09%	★★★★★☆
Tenaya Therapeutics	61.22%	63.08%	★★★★★☆
Duos Technologies Group	36.60%	141.19%	★★★★★☆

Let's dive into some prime choices out of from the screener.

Rezolute (RZLT)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Rezolute, Inc. is a late-stage rare disease company dedicated to enhancing outcomes for individuals with hypoglycemia due to hyperinsulinism in the United States, with a market cap of $344.74 million.

Operations: Rezolute focuses on developing treatments for rare diseases, specifically targeting hypoglycemia caused by hyperinsulinism. The company is in the late stages of development and operates primarily within the United States.

Rezolute, Inc. is navigating a challenging landscape with its innovative ersodetug treatment for congenital hyperinsulinism, despite not meeting primary endpoints in recent studies. The company's revenue growth is projected at an impressive 75.6% annually, outpacing the US market average of 11.6%. However, it remains unprofitable with a net loss reducing from $18.91 million to $16.17 million year-over-year in the latest quarter. Promisingly, R&D efforts continue to show potential therapeutic benefits and statistically significant glycemic improvements during maintenance phases of their trials, suggesting a strong focus on advancing medical treatments through substantial investment in research and development activities.

SELLAS Life Sciences Group (SLS)

Simply Wall St Growth Rating: ★★★★★☆

Overview: SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company dedicated to developing novel cancer therapeutics in the United States, with a market cap of $971.09 million.

Operations: SELLAS Life Sciences Group, Inc. focuses on developing innovative cancer therapeutics as a late-stage clinical biopharmaceutical company in the U.S. With a market capitalization of approximately $971.09 million, the company's financial details regarding revenue segments are not disclosed.

SELLAS Life Sciences Group, despite a challenging financial landscape marked by a net loss increase from $5.81 million to $8.41 million in Q1 2026, is making notable strides in biotechnological innovation. The company's aggressive R&D focus is evidenced by its development of SLS009 (tambiciclib), which has shown increased efficacy in preclinical trials against acute myeloid leukemia, particularly in models resistant to traditional treatments. This aligns with an impressive forecasted revenue growth rate of 67.2% per year, significantly outpacing the US market average of 11.6%. Moreover, earnings are expected to surge by approximately 63.57% annually over the next few years, highlighting potential for future profitability and underscoring its commitment to advancing cancer treatment through scientific breakthroughs and targeted therapy development.

Harmonic (HLIT)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Harmonic Inc., along with its subsidiaries, delivers broadband access solutions globally and has a market capitalization of approximately $1.40 billion.

Operations: Harmonic Inc. generates revenue primarily through its broadband access solutions offered worldwide. The company's financial performance is characterized by a focus on delivering innovative technology to support the growing demand for high-speed internet and video services.

Harmonic's recent performance underscores its strategic advancements in the tech sector, with a notable increase in Q1 2026 revenue to $121.7 million from $84.88 million year-over-year. This growth is complemented by a rise in net income to $7.31 million, up from $5.94 million, reflecting robust operational efficiency and market adaptation. The firm's forward-looking guidance anticipates continued revenue growth, projecting between $475 million and $495 million for 2026, alongside an operating profit of up to $78 million. These figures highlight Harmonic's effective management and innovative edge in broadband technologies, particularly through its AI-driven solutions for network operations which enhance connectivity and subscriber experiences across diverse platforms.

Where To Now?

• Discover the full array of 66 US High Growth Tech and AI Stocks right here.
• Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.